Phase Four Trials and Drug Safety Evidence

E-ISSN： 2055-2335|42|3|179-179

ISSN： 1445-937x

Source： JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol.42, Iss.3, 2012-09, pp. : 179-179

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Randomized Controlled Trials and Assessment of Drug Safety

By Clark David W.J.

Drug Safety, Vol. 31, Iss. 12, 2008-01 ,pp. : 1057-1061

Adis International

Access to resources Recommend Favorite

Data Safety Monitoring Boards: Their Role in Drug Development and Pharmaceutical Trials

By Boardman H.

International Journal of Pharmaceutical Medicine, Vol. 17, Iss. 1, 2003-01 ,pp. : 39-46

Adis International

Access to resources Recommend Favorite

Current Issues in Oncology Drug Development, with a Focus on Phase II Trials

By Sargent Daniel

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 3, 2009-05 ,pp. : 556-562

Taylor & Francis Ltd

Access to resources Recommend Favorite

Criteria of Evidence to Move Potential Chemopreventive Agents into Late Phase Clinical Trials

Current Drug Targets, Vol. 12, Iss. 13, 2011-12 ,pp. : 1983-1988

Bentham Science Publishers

Access to resources Recommend Favorite

Evidence-Based Medicine Criteria Applied to Hypolipidemic and Antihypertensive Drug Trials: Is Drug Efficacy Always the Same?

By Calabresi L. Sirtori C.R.

Pharmacological Research, Vol. 37, Iss. 5, 1998-05 ,pp. : 339-343

Academic Press

Access to resources Recommend Favorite